Efecto de un suplemento nutricional utilizado en tratamientos farmacológicos sobre la glicemia en pacientes diabéticos tipo 2

Jorge Luis Díaz-Ortega, Marlon Farfán-Córdova, Julio César Horna Quiñones

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Objective: To compare the effect of a nutritional supplement used as a replacement meal in different pharmacological treatments on glycemia in patients with type 2 diabetes mellitus. Methods: Three groups of patients with diabetes were treated with pharmacological treatments: Group 1 Biguanide (08), Group 2 inhibitor of dipeptidyl peptidase-4 (07) and Group 3 Sulphonylurea/Biguanide (09). Glucerna® (Abbott Laboratories) supplementation was suggested to patients in the 3 groups. The initial glycemia in the three groups was: 206.13 ± 78.99 mg/dL; 276.14± 103.24 mg/dL and 310.89± 88.49 mg/dL for groups G1, G2 and G3 respectively. Regarding the glycemia evaluation, a basal and two post-treatments (control 1 and 2) were performed using the glucose oxidase-peroxidase method. Results: There was a significant decrease in glycemia in control 1 and 2 compared to baseline in patients with different pharmacological treatments and glycerine G1: 96.62± 58.88 mg/dL and 108.95± 78.25 mg/dL; G2: 147.97± 86.19 mg/dL and 153.86± 97.75 mg/dL; G3: 140.67± 37.42 mg/dL and 179.87± 70.71 mg/dL, however, when comparing the glycemia reduction of the controls in the three groups was not significant (p > 0.05). Conclusions: There is no significant difference in the decrease of glycemia in diabetic patients and in the use of nutritional supplement (Glucerna®) in different pharmacological treatments.

Título traducido de la contribuciónEffect of a nutritional supplement used in pharmacological treatments on glycaemia in diabetic patients type 2
Idioma originalEspañol
PublicaciónRevista Cubana de Farmacia
Volumen51
N.º4
EstadoPublicada - 1 oct. 2017
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2017 Revista Cubana de Farmacia. All rights reserved.

Palabras clave

  • Biguanide
  • Diabetes mellitus type 2
  • Dipeptidyl peptidase-4
  • Glucerna
  • Sulfonylurea

Huella

Profundice en los temas de investigación de 'Efecto de un suplemento nutricional utilizado en tratamientos farmacológicos sobre la glicemia en pacientes diabéticos tipo 2'. En conjunto forman una huella única.

Citar esto